Dr. Ran Schwarzkopf, MD
Claim this profileNYU Langone Health
Studies Osteoarthritis
Studies Hip Dislocation
12 reported clinical trials
18 drugs studied
Affiliated Hospitals
Clinical Trials Ran Schwarzkopf, MD is currently running
Antibiotic Prophylaxis
for Knee Replacement Surgery
The Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty (TKA): Multi-Center Trial is a study that will compare the effectiveness of various perioperative strategies for antibiotic delivery as prophylaxis for periprosthetic joint infections (PJI) and surgical site infection in elective primary TKA. The investigators hypothesize that a single dose of prophylactic antibiotic administered within 60 minutes before the incision is not an effective way to prevent PJI in elective primary total knee arthroplasty (TKA). The investigators also hypothesize that the prolonged delivery (24 hours) of antibiotic prophylaxis after surgery does not further reduce the incidence of PJI in elective primary TKA. Duke University is the only site recruiting both primary total knee arthroplasty and unilateral knee arthroplasty.
Recruiting3 awards Phase 4
Dual Mobility Implants
for Hip Dislocation
The aim of this study is to compare clinical outcomes of patients considered to be high risk for prosthetic dislocation undergoing primary total hip arthroplasty (THA) with the use of a dual mobility bearing versus a conventional, single bearing design.
Recruiting3 awards Phase 42 criteria
More about Ran Schwarzkopf, MD
Clinical Trial Related9 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Ran Schwarzkopf, MD has experience with
- Two-stage Exchange Arthroplasty
- VT-X7 Treatment System
- Vancomycin Powder
- Conventional
- Povidone Iodine
- Ensure
Breakdown of trials Ran Schwarzkopf, MD has run
Osteoarthritis
- A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis
- Nutritional Supplements for Joint Replacement Recovery
- Infection Prophylaxis with Vancomycin + Povidone Iodine for Post-Surgical Joint Infections
Hip Dislocation
Infections
Arthritis
Total Knee Replacement
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ran Schwarzkopf, MD specialize in?
Ran Schwarzkopf, MD focuses on Osteoarthritis and Hip Dislocation. In particular, much of their work with Osteoarthritis has involved treating patients, or patients who are undergoing treatment.
Is Ran Schwarzkopf, MD currently recruiting for clinical trials?
Yes, Ran Schwarzkopf, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Ran Schwarzkopf, MD has studied deeply?
Yes, Ran Schwarzkopf, MD has studied treatments such as Two-stage exchange arthroplasty, VT-X7 Treatment System, Vancomycin powder.
What is the best way to schedule an appointment with Ran Schwarzkopf, MD?
Apply for one of the trials that Ran Schwarzkopf, MD is conducting.
What is the office address of Ran Schwarzkopf, MD?
The office of Ran Schwarzkopf, MD is located at: NYU Langone Health, New York, New York 10016 United States. This is the address for their practice at the NYU Langone Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.